Cerevel Therapeutics Holdings Inc. (CERE)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
24 |
$17,359,702 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
18 Oct 2023 |
BAIN CAPITAL INVESTORS LLC |
10% |
16 Oct 2023 |
5,480,052 |
22.81 |
124,999,986 |
17 Oct 2023 |
PERCEPTIVE ADVISORS LLC |
Director |
16 Oct 2023 |
876,808 |
22.81 |
19,999,990 |
07 Aug 2023 |
RENAUD RONALD C JR |
President & CEO |
03 Aug 2023 |
83,857 |
23.96 |
2,008,811 |
07 Aug 2023 |
BURGESS PAUL D. |
See Remarks |
04 Aug 2023 |
21,880 |
22.93 |
501,794 |
18 Aug 2022 |
PERCEPTIVE ADVISORS LLC |
Director |
16 Aug 2022 |
1,425,000 |
35.00 |
49,875,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock